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A full-length cDNA clone was constructed from the genome of the human parainfluenza type 2 virus (hPIV2). First, Vero
cells were infected with recombinant vaccinia virus expressing T7 RNA polymerase, and then the plasmid encoding the
antigenome sequence was transfected into Vero cells together with polymerase unit plasmids, NP, P, and L, which were under
control of the T7 polymerase promoter. Subsequently, the transfected cells were cocultured with fresh Vero cells. Rescue of
recombinant hPIV2 (rPIV2) from cDNA clone was demonstrated by finding the introduced genetic tag. As an application of
reverse genetics, we introduced one nucleotide change (UCU to ACU) to immediate downstream of the RNA-editing site of
the V gene in the full-length hPIV2 cDNA and were able to obtain infectious viruses [rPIV2V(2)] from the cDNA. The rPIV2V(2)
possessed a defective V protein that did not have the unique cysteine-rich domain in its carboxyl terminus (the V-protein-
specific domain). The rPIV2V(2) showed no growth in CV-1 and FL cells. Replication of the rPIV2V(2) in these cells, however,
was partially recovered by adding anti-interferon (IFN)-b antibody into the culture medium, showing that the rPIV2V(2) is
highly sensitive against IFN and that no growth of rPIV2V(2) in CV-1 and FL cells is mainly due to its hypersensitivity to
endogenously produced IFN. These findings indicate that the V-protein-specific domain of hPIV2 is related to IFN resistance.
On the other hand, the rPIV2V(2) efficiently replicated in Vero cells, which are known as a IFN-non-producers. However, the
virus yields of rPIV2V(2) in Vero cells were 10- to100-fold lower than those of control rPIV2, although syntheses of the
viral-specific proteins and their mRNAs in rPIV2V(2)-infected Vero cells were augmented up to 48 p.i. in comparison with
those of rPIV2. Furthermore, the rPIV2V(2) virions showed anomalous in size as compared with rPIV2 virions. These results
suggest that the V protein plays an important role in the hPIV2 assembly, maturation, and morphogenesis. © 2001 Academic
Press
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Human parainfluenza type 2 virus (hPIV2) is one of the
major human respiratory pathogens and a member of the
genus Rubulavirus in the family Paramyxoviridae, pos-
sessing a single-stranded, nonsegmented, and negative-
stranded RNA genome of ;15.6 kb. The genome of
hPIV2 encodes seven mRNAs (Kawano et al., 1990a–c,
991; Ohgimoto et al., 1990; Yuasa et al., 1991) and has an
60-nt leader sequence at 39 end and an ;20-nt non-
oding trailer sequence. The gene order is 39-(leader)-
P-V/P-M-F-HN-L-(trailer)-59. The coding proteins are the
ucleocapsid (NP), the V (V) and phospho (P), the matrix
M), the fusion (F), the hemagglutinin-neuraminidase
HN), and the polymerase protein (L). The genomic RNA
f the virus [viral RNA (vRNA)] is encapsidated with the
P proteins, resulting in nuclease-resistant helical nu-
1 To whom reprint requests should be addressed at Department of
icrobiology, Mie University School of Medicine, 2-174, Edobashi, Tsu,Vie 514-8507, Japan Fax: 181-59-231-5008. E-mail: kawanom@
oc.medic.mie-u.ac.jp.
99leocapsids, and the nucleocapsids were associated
ith the P and L proteins to form the ribonucleoprotein
omplex. The viral polymerase complex (RNA-dependent
NA polymerase), which consists of the L and P proteins,
s probably thought to be responsible for RNA transcrip-
ion and replication, termination, and reinitiation at gene
unction, capping, and polyadenylating all mRNAs, but
hese have yet to be demonstrated. The vRNA also
erves as a template for the synthesis of a full-length
ositive-sense complementary RNA, which is replicative
ntermediate. Most paramyxoviruses have the unique
roperty of promoting the transcription of mRNA contain-
ng nontemplated insertions at a specific site in the P
ene carrying a part of viral RNA polymerase (Thomas et
l., 1988; Cattaneo et al., 1989; Vidal et al., 1990; Paterson
nd Lamb, 1990; Ohgimoto et al., 1990; Kondo et al., 1990;
awano et al., 1993). In hPIV2 RNA editing, the pseudo-
emplated addition of two G residues produces an mRNA
hat encodes the protein termed P, while the unedited
RNA that is the exact copy of the P gene encodes the
protein.
The construction of functional RNA replicons from
0042-6822/01 $35.00
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100 KAWANO ET AL.cDNA and the successful recovery of infectious recom-
binant viruses have greatly facilitated the molecular ge-
netic analyses of RNA viruses. Until recently, this tech-
nology was applicable only to positive-stranded RNA
viruses because, in contrast to the situation with posi-
tive-stranded RNA viruses, the deproteinized genomic
RNA of negative-stranded viruses is not infectious, and
RNA, with negative or positive polarity, transcribed from
full-length cDNA clones of the genomes of negative-
stranded RNA viruses, is not by itself competent to initi-
ate infection.
An efficient system completely devoid of infectious
helper virus was first used for vesicular stomatitis virus
(VSV), a member of the Rhabdoviridae family. Intracellu-
larly transcribed synthetic RNA corresponding to the
genome of a nonexpressing natural VSV copyback-type
defective interfering (DI) particle was rescued by VSV
proteins expressed from the plasmids (Pattnaik et al.,
1992). This system employed bacteriophage T7 DNA-
dependent RNA polymerase, which was expressed cy-
toplasmically from a vaccinia virus (VV) recombinant
[vTF7-3 (Fuerst et al., 1986)]. The T7 polymerase synthe-
sized DI particle genomic RNA from circular transcription
plasmids that were introduced into the cells by transfec-
tion. Finally, in the presence of the complete complement
of five VSV proteins expressed from the plasmids, the
replicated DI RNA transcripts were incorporated into
infectious DI particles that budded and were released
from the cells.
Attempts to manipulate the full-length genome of the
mononegavirus were facilitated by studies using the
methods described above. These procedures were then
extended to allow the rescue from the cloned DNA of
infectious virus. The initial success was the recovery of
rabies virus by Schnell et al. (1994). Their methods using
a plasmid encoding a full-length antigenomic viral RNA
became a key to recovery of nonsegmented and nega-
tive-stranded RNA virus from cDNA. Application of this
system led to success of the rescue from the cDNA of
infectious VSV, measles virus (MV), human respiratory
syncytial virus (RSV), Sendai virus (SV), human parainflu-
enza virus type 3 (PIV3), simian virus 5 (SV5), Newcastle
disease virus (NDV), and mumps virus (MuV) (Lawson et
al., 1995; Whelan et al., 1995; Radecke et al., 1995; Collins
et al., 1995; Garcin et al., 1995; Kato et al., 1996; Hoffman
and Banerjee, 1997; Durbin et al., 1997; He et al., 1997;
Peeters et al., 1999; Clarke et al., 2000).
As the applications of reverse genetics to these re-
combinant viruses, the elimination of alternative gene
products encoded in the P genes to elucidate their roles
in viral replication and pathogenesis was carried out.
Recombinant viruses deleting the VSV C/C9 proteins
(Kretzschmar et al., 1996), Sendai virus V protein (Kato et
al., 1997), Sendai virus C/C9 proteins and C/C9/Y1/Y2
proteins (Garcin et al., 1997; Kurotani et al., 1998), and
MV C protein (Radecke et al., 1996) have been gener-ated. Among these deleting mutant viruses, some muta-
tions in the Sendai virus showed significant effects on
viral replication. Compared with the wild-type Sendai
virus in various cell line in vitro, the V protein knockout
[V(2)] virus was found to be either potentiated or com-
parable but never attenuated. However, the V(2) virus
showed remarkably attenuated in vivo replication capac-
ity and pathogenicity for mice (Kato et al., 1997). A point
mutation in the Sendai virus C proteins attenuated viru-
lence for mice but not virus growth in cell culture (Garcin
et al., 1997). The 4C knockout [4C(2)] Sendai virus, which
expresses none of the four C proteins, was further atten-
uated in tissue culture as compared with the C/C9(2) or
V(2) virus (Kurotani et al., 1998).
Furthermore, among the defective C(2) viruses, only
the 4C(2) virus eliminated the viral ability to prevent the
interferon (IFN)-a/b-mediated responses (Gotoh et al.,
1999). Thus, in the Sendai virus, the anti-IFN function is
attributed to the C proteins; Didcock et al. (1999), how-
ever, have reported that the V protein of simian virus 5
belonging to the Rubulavirus inhibits IFN signaling by
targeting STAT1, which is degraded by the enhanced-
proteasome activity.
In this report, we described the construction and gen-
eration of hPIV2 full-length infectious cDNA clones. For
the purpose of studying functions of V protein in the
Rubulavirus by using this reverse genetics system, we
generated a V protein-negative virus by introducing one
nucleotide change to downstream of the RNA-editing site
and analyzed its properties.
RESULTS
Construction of cDNA to hPIV2 genome
To construct a cDNA clone encoding the full-length
hPIV2 genome, we attempted to ligate the long RT–PCR
fragments produced by restriction enzymes, which cut
one site on cDNA for hPIV2-vRNA. We were able to find
those sites, SacI on V/P gene (2673), KpnI on HN gene
(8137), and BstPI on L gene (10,027) (Fig. 1). We synthe-
sized appropriate oligonucleotide primer pairs as shown
in Table 1 and performed the RT–PCR using vRNA as a
template. Five overlapping cDNA fragments (Fig. 1) syn-
thesized by RT–PCR were digested by unique restriction
enzyme in both termini and ligated to similarly digested
pUC118RVG plasmid vector (see Materials and Meth-
ods), respectively. Then, a plasmid including the full-
length hPIV2 cDNA genome (pPIV2) was constructed by
step-wise assembly from these subcloned plasmid
DNAs. Finally, as shown in Fig. 1, we constructed pPIV2
including the hPIV2 full-length cDNA with additional ge-
netic tag (NotI) flanked on its left end by a T7 RNA
polymerase promoter and at the right end by a hepatitis
delta virus ribozyme followed by a T7 terminator, and 3G
residues were also inserted before the hPIV2 leader
sequence for the purpose of increasing the transcription
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101RECOVERY OF V KNOCKOUT RECOMBINANT HPIV2efficiency by T7 RNA polymerase. Transcription of pPIV2
by T7 RNA polymerase produced the hPIV2 full-length
antigenome (1) sense RNA transcript.
Construction of a hPIV2 genome cDNA-retaining
defective V gene
To elucidate the function of the hPIV2 V protein, we
introduced a TGA stop codon in the V frame, immediate
downstream of the RNA editing site by mutating 2507A to
(U to A in the genomic sense) in the plasmid pPIV2,
enerating a full-length copy of hPIV2 antigenome (Fig.
). This mutated plasmid was designated pPIV2V(2).
his mutation did not show any effect on the P frame.
FIG. 1. Schematic diagram of the full-length infectious clone, pPIV2 a
DNA was constructed from five overlapping RT–PCR cDNA fragments
rg. 5 (BstPI–SmaI). pPIV2 contains the full-length cDNA of hPIV2 geno
DV ribozyme (Ribo) and a T7 terminator (T7-T). pPIV2 contains three e
site added on NP gene shows the genetic tag found in the recovered
construction of the plasmids, pPIV2V(2), encoding defective V protein
T
Primers Used to Construct the F
Primer 1 59-ACGCGTCGACTAATACGACTCACTATA
SalI PT7
Primer 2 59-ATAGTTTAGCGGCCGCAGATAGAGAAT
NotI
Primer 3 59-ATAAGAATGCGGCCGCATCTCTATTAA
NotI
Primer 4 59-CAAGTCCCTTTAAGAGCTCAATGATCTC
SacI
Primer 5 59-TGAAGGAGATCATTGAGCTCTTAAAGG
SacI
Primer 6 59-ACTTGATAGGACGGTACCCATTGAGCC
KpnI
Primer 7 59-CATTGAGGCTCAATGGGTACCGTCCTA
KpnI
Primer 8 59-TTTTCTTTCTACGGTAACCATTAATTAAA
BstPI
Primer 9 59-ACAATTTTAATTAATGGTTACCGTAGAA
BstPI
SmaI
Primer 10 59-TCCCCCGGGCTCCCTTAGCCATCCGAG
GGTGGAGATGCCATGCCGACCCACCA
Ribo (84 nt)ecovery of infectious hPIV2 from cDNA
To recover infectious recombinant hPIV2 from cDNA,
ero cells were infected with a recombinant vaccinia
irus (MVA) that expresses T7 RNA polymerase and
auses lower cytopathic effects than vTF7-3 (Wyatt et
l.,1995), and after 2 h, the cells were transfected with
PIV2 together with the plasmids that encode hPIV2
olymerase units, NP, P, and L proteins. The amount of
ach plasmid used for hPIV2 rescue (see Materials and
ethods) was referred to the success in rescuing infec-
ious SV5 (He et al.,1997). The recovery procedure was
s follows; Vero cells cultivated in six-well plates were
ransfected with the above plasmids. After 6 h, the me-
2V(2), essential to making an antisense genome RNA. The full-length
(SalI–NotI), frg. 2 (NotI–SacI), frg. 3 (SacI–KpnI), frg. 4 (KpnI–BstPI), and
is flanked at one end by a T7 promoter (PT7) and at the other end by
residues between PT7 and the hPIV2 leader (Le) sequence. The NotI
s. The arrow shows one nucleotide change introduced into pPIV2 for
t V specific cysteine-rich C terminus.
gth cDNA of the PIV2 Genome
CAAGGGGAGAATCAGATGG-39
Le (21 nt)
GATAGTAT-39
TTTCTAGTCTAAAG-39
A-39
G-39
G-39
T-39
-39
A-39
CGTGCGTCCTCCTTCGGATGCCCAGGTCGGACCGCGAGGA
AAAATCAATATGTTTTTC-39nd pPIV
, frg. 1
me and
xtra GABLE 1
ull-Len
GGGAC
GATCA
GGATA
CTTC
GACTT
TCAAT
TCAAG
ATTGT
AGAAA
TGGA
AGGGGTr (27 nt)
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102 KAWANO ET AL.dium was changed followed by incubation for a further
40 h. The cells were harvested and cocultured with fresh
Vero cells. After 48 h-incubation, the media were har-
vested and then inoculated into Vero cells, which were
further incubated for 48 h. The supernatant was filtered
through 0.22-mM filter to remove vaccinia virus and was
sed to further infect Vero cells. After incubation for 24 h,
arge numbers of typical foci of hPIV2-induced syncytia
ith hemadsorption activity were observed (data not
hown). The virus rescue from pPIV2V(-) cDNA was per-
ormed according to almost the same methods de-
cribed above, but the cocultures of transfected cells
ith fresh Vero cells were done twice every 48 h before
arvest of the media.
dentification of virus rescue by RT–PCR and Western
lot assay
To investigate whether the infectious viruses were
roduced from the cDNA, we purified reverse-tran-
cribed vRNA from putative rPIV2- or rPIV2V(2)-infected
ells using primers that annealed close to the genetic
ag (NotI site) introduced at nt 126 to 137. The RT prod-
cts were then amplified by PCR using a second primer
o generate a fragment covering the genetic tag. As
hown in Fig. 2A, an appropriately sized DNA fragment
385 bp) was found only in complete reaction. When RT
as omitted from the reaction, no proper-size PCR prod-
ct was found (data not shown). Restriction endonucle-
se digestion by NotI showed that the expected NotI site
as present in the RT–PCR fragment derived from vRNA
f either a putative rPIV2 or rPIV2V(2) but not in that from
arental hPIV2. Furthermore, the nucleotide sequencing
f the RT–PCR fragments proved the existence of the
dditional NotI site in the rPIV2 and rPIV2V(2) (Fig. 2B),
ndicating the rescue of infectious recombinant hPIV2
rom the cDNA clone. Then, the nucleotide sequencing of
utated site in rPIV2V(2) was performed using RT–PCR
ragment covering the RNA-editing site in the P gene,
nd the rescue of rPIV2V(2) from the cDNA clone was
lso reconfirmed (Fig. 2B).
To study whether the mutation (stop codon) introduced
nto the V gene of pPIV2 could fulfilled its function in virus
ranscription by the rPIV2 polymerase, we carried out the
estern blot assay using the rPIV2V(2)- or rPIV2-in-
ected Vero cell lysate and the specific monoclonal an-
ibody against the NP or the P/V protein of hPIV2 (Tsu-
udome et al., 1989; Nishio et al., 1999). As shown in Fig.
C, the rPIV2V(2) was found to synthesize no detectable
protein, whereas the NP and P proteins were clearly
etected in the virus-infected cells. All these proteins
ere detectable in the rPIV2-infected cells. Furthermore,
he lower-molecular-weight polypeptide (MW of ; 24K)
as detected only in rPIV2V(2)-infected cells (Fig. 2C),
nd the polypeptides were considered to be I-like protein
bserved in mumps virus-infected cells (Paterson andamb, 1990), indicating that gene manipulation of vRNA,
amely, introduction of mutation, gets along well.
ene expression and replication of rPIV2 and
PIV2V(2) in Vero cells
Subsequently, we analyzed the growth of rPIV2 and
PIV2V(2) in Vero cells under multiple-cycle growth con-
itions (an m.o.i. of 0.001). Figure 3A shows rPIV2V(2)
xhibits a slower kinetics than rPIV2 throughout the
xperimental period. The virus titer of rPIV2V(2) was
educed by 10- and 100-fold as many as that of rPIV2 at
8 and 72 p.i., respectively, that is, the virus yield of rPIV2
as ;3 3 105 TCID50/ml at 72 h p.i., while that of
PIV2V(2) was ;3 3 103 TCID50/ml at 72 h p.i. (Fig. 3A),
ndicating that rPIV2V(2) is remarkably attenuated in
ero cells.
Then, the viral polypeptides synthesized in rPIV2- and
PIV2V(2)-infected Vero cells under the multiple-cycle
rowth conditions were analyzed by Western blot assay
sing anti-hPIV2 NP and P/V antibodies. The level of NP
nd P protein synthesis was much higher in the
PIV2V(2)-infected cells #48 p.i. than that in the rPIV2-
infected cells (Fig. 3B). These findings exhibit a striking
contrast to the virus yields (Fig. 3A). Interestingly, how-
ever, the protein synthesis of rPIV2 rapidly increased at
72 h p.i., while the synthesis rate of virus-specific pro-
teins was gradually increasing in rPIV2V(2)-infected
cells after 48 h p.i. The data also confirmed that the V
protein was lacking in rPIV2V(2).
In the next experiment, the level of virus transcrip-
tion and genome replication in the same infected cells
was analyzed by RT–PCR/Southern. The kinetics pat-
terns between the virus proteins and mRNAs synthe-
ses paralleled. On the other hand, vRNA synthesis was
not augmented in rPIV2V(2)-infected cells from 24 to
48 h p.i. (Fig. 3C). Intriguingly, though the virus yield of
rPIV2V(2) at 72 h p.i. was as many as that of rPIV2 at
48 h p.i., the synthetic quantities of the viral proteins
and mRNAs of rPIV2V(2) at 72 h p.i. were more than
those of rPIV2 at 48 h p.i (Fig. 3C), suggesting that the
function of assembly and/or maturation of rPIV2V(2) is
insufficient.
Electron microscopical observation of the rPIV2 and
rPIV2V(2)
To further clarify an influence of V protein loss on
the viral morphology, the virions of rPIV2, rPIV2V(2),
and wtPIV2 grown in Vero cells were examined by an
immunoelectron microscopy using mouse anti-hPIV2
HN monoclonal antibody, followed by labeling with
goat anti-mouse IgG antibody-colloidal gold particles
and negative staining. The wtPIV2 and rPIV2 prepara-
tions displayed a relatively homogenous population of
spherical particles with a diameter of ;100 ; 200 nm
(Figs. 4A, 4B, and 4D), and mean diameters of wtPIV2
103RECOVERY OF V KNOCKOUT RECOMBINANT HPIV2FIG. 2. Identification of virus rescue by RT–PCR amplification and by Western blotting from rPIV2- or rPIV2V(2)-infected Vero cells. (A)
Demonstration of the genetic tag in the genome of transfectant recombinant viruses, rPIV2 and rPIV2V(2): template RNAs for the amplifications were
obtained from rPIV2V(2) (lanes 1 and 2), from rPIV2 (lanes 3 and 4), or from wtPIV2 (lanes 5 and 6). The amplified DNA spanning the NotI site on the
virus genome was separated on a 2% agarose gel before (lanes 1, 3, and 5) and after digesting with NotI (lanes 2, 4, and 6). (B) Nucleotide sequencing
of genetic tag and mutated site in the V gene from RT–PCR products: RT–PCR products of recombinant viruses shown in (A) were subcloned and
sequenced on an ABI 310 sequencer according to the manufacturer’s protocols. Top row shows the nucleotide sequences of the region around
genetic tag and around RNA-editing site of rPIV2 genome RNA. Bottom row shows the nucleotide sequences over the same regions of rPIV2V(2)
genome RNA. (C) Absence of V protein synthesis in Vero cells infected with the rPIV2V(2): the lysates of Vero cells infected with the rPIV2V(2) (lanes
2 and 5) or rPIV2 (lanes 3 and 6) were analyzed by Western blotting with hPIV2-specific monoclonal antibodies against P/V (lanes 2 and 3) and NP
proteins (lanes 5 and 6). Lane 1: molecular markers. * indicate the degraded products of the P or NP protein.
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104 KAWANO ET AL.and rPIV2 were 175 and 165 nm, respectively, which
shows the typical character of paramyxovirus virions.
Typical nucleocapsid strands were also clearly seen,
and they were enclosed with the envelope as typical
paramyxoviruses. On the other hand, the rPIV2V(2)
particles consisted of greatly heterogeneous popula-
tion, and mean diameter of rPIV2V(2) was 222 nm.
Furthermore, larger spherical particles with a diameter
of ;250 ; 500 nm were frequently found (Figs. 4C and
D). Diameter was significantly larger in rPIV2V(2)
FIG. 3. Replication of rPIV2 or rPIV2V(2) in Vero cells under multipl
rPIV2V(2) in Vero cells: after infection with an m.o.i. of 0.001, virus titers
and virus titers were expressed as 50% tissue culture infectious dose (T
by solid triangles (). (B) Western blot analysis: expressions of the
rPIV2-infected Vero cells (lanes 5–7) by Western blot analysis using ant
kinetics by RT–PCR/Southern of viral mRNAs and genomic RNA derived
of the viral mRNAs and genomic RNA were analyzed in Vero cells infearticles than in either wtPIV2 or rPIV2 particles (P ,
.05).
t
mrowth of rPIV2 and rPIV2V(2) in CV-1 and FL cells
It has recently been reported that the V protein of SV5
nhibits interferon (IFN) signaling by targeting STAT1
Didcock et al., 1999). Thus, we investigated whether the
rowth of rPIV2V(2), which is defective in the unique
-specific cysteine-rich C terminus, was affected by IFN
ystem. Under multiple-step replication conditions with
n m.o.i. of 0.01, the growth of rPIV2V(2) in CV-1 and FL
ells was compared with that of rPIV2. rPIV2 could rep-
icate efficiently in CV-1 and FL cells, although maximum
growth conditions (m.o.i. of 0.001). (A) The virus growth of rPIV2 and
etermined at the indicated time points by CPE method using Vero cells
The titer of rPIV2 is indicated by solid circles (F) and that of rPIV2V(2)
and V proteins were analyzed in rPIV2V(2)-infected (lanes 2–4) and
P/V and anti-hPIV2 NP antibodies. Lane 1: molecular markers. (C) The
PIV2V(2) or rPIV2 using hPIV2- and actin-specific probes. Expressions
ith rPIV2V(2) or rPIV2 for 24, 48, and 72 h.e cycle
were d
CID50).
NP, P,
i-hPIV2iters of rPIV2 in FL cells were reduced by ;10-fold as
uch as those in CV-1 cells (Figs. 5A and 5B). On the
ns of w
m nm. (D)
105RECOVERY OF V KNOCKOUT RECOMBINANT HPIV2contrary, no growth of rPIV2V(2) could be detected in
both cells. Since Vero cells were regarded as an IFN
nonresponder, we investigated whether the neutraliza-
tion of the endogenously produced IFN might affect the
yield of rPIV2V(2) in CV-1 and FL cells. As shown in Figs.
5A and 5B, anti-IFN-b antibody shows no effect on the
growth of rPIV2 in CV-1 and FL cells. On the other hand,
the yield of rPIV2V(2) was clearly enhanced in the pres-
ence of anti-IFN-b antibody (Figs. 5A and 5B), although
maximum titer of rPIV2V(2) was lower than that of rPIV2.
These observations indicate that the rPIV2V(2) is highly
sensitive to IFN and that no growth of rPIV2V(2) in CV-1
and FL cells is mainly due to its hypersensitivity to
endogenously produced IFN.
When FL cells was infected with rPIV2V(2), CPE de-
veloped during first 2 days and thereafter cell damage
was cured (Fig. 6A), indicating that the growth of the V
FIG. 4. Electron microscopy of viral particles. (A–C) The purified virio
icroscopy using anti-hPIV2 HN monoclonal antibody. Bars indicate 100knockout hPIV2 in FL cells is self limited. However, the
cell damage induced by rPIV2V(2) was expanded in Verocells as the infected cells were cultured and finally the
greater part of the cells died (Fig. 6A). On the contrary,
infection of Vero and FL cells with rPIV2 resulted in the
total cell death (Fig. 6B). Interestingly, anti-IFN-b anti-
body partially enhanced the rPIV2V(2)-induced CPE in
FL cells. These findings show that self-limiting growth of
V(2) hPIV2 is, in part, related to IFN.
DISCUSSION
In this work, we established the recovery system of
infectious recombinant hPIV2 (rPIV2) from the full-length
cDNA constructs. In addition, we isolated the V protein
knockout hPIV2 [rPIV2V(2)], which is defective in the
V-specific cysteine-rich domain by introducing mutations
(stop codon) into the full-length cDNA genome.
The genome length of members belonging to the gen-
tPIV2 (A), prPIV2 (B), and rPIV2V(2) (C) were observed by an electron
The diameters of wtPIV2, rPIV2, and rPIV2V(2) virions were measured.era Respirovirus and Rubulavirus is known 6n length,
called the “rule of six” (Calain and Roux, 1993). However,
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106 KAWANO ET AL.the previously reported hPIV2 genome length were not
6n length. Hence, at least three different RT–PCR clones
of hPIV2 were sequenced, and one nucleotide deletion
was found in 39-noncoding region of HN gene in previ-
ously reported hPIV2 sequence (data not shown). This
result indicated the total number of nucleotides in the
correct hPIV2 genome was a multiple of six. For SV, it
was found that efficient replication of the genome only
occurred when the total nucleotide numbers obey the
“rule of six” (Calain and Roux, 1993). However, Murphy
and Parks (1997) suggested that the genome of 6n length
was a preference but not absolute requirement for SV5
replication. Although the full-length cDNA used for the
rescue of rPIV2 was not 6n length (15,665 nt including
genetic tag), infectious virus could be isolated, and the
recombinant virus could efficiently replicate in various
cells. The full-length cDNA has one nucleotide deletion
in the 39-noncoding region of M gene. Nevertheless, the
replication and transcription of rPIV2 showed the kinetics
comparable to wtPIV2 (unpublished data). Thus, likewise
SV5, hPIV2 does not appear to absolutely obey to the
“rule of six,” suggesting that 6n length genome has less
significance in Rubulavirus than in Respirovirus.
For the rescue of hPIV2 from cDNA, we used the
strategy performed by Schnell et al. (1994), who trans-
FIG. 5. Growth of rPIV2 and rPIV2V(2) in CV-1 and FL cells. CV-1 (A
ultiple-cycle growth conditions (an m.o.i. of 0.01) in the presence (- -
he indicated time points by CPE method using Vero cells and virus tifected the anti-genome RNA strand of rabies virus to the
cells. The rescues of infectious recombinant virus from
h
bcDNAs of SV and hPIV3 in the genus Respirovirus, SV5,
MuV, and NDV in the genus Rubulavirus have recently
succeeded by application of their system. To establish
the recovery system of hPIV2 from cDNA clone, we
employed the methods that were used for the isolation of
recombinant SV5 closely related to hPIV2 (He et al.,
1997). Since the efficiency of the rescue of rPIV2 was
poor as compared with other recombinant viruses, we
were not able to isolate infectious virus in the superna-
tant of first cells (;5 3 106) transfected with plasmids
omplex. Accordingly, we attempted to coculture whole
ransfected cells with fresh Vero cells (the ratio of 1:1) for
days. After this cocultivation, we could isolate a few
nfectious viruses in the culture fluids.
The P gene is the second proximal to the 39 terminus
n virus genome in the family Paramixoviridae and fre-
uently encodes one or more other small polypeptides,
nd also RNA-editing to insert pseudotemplated G resi-
ues is found for all the three paramyxovirus genera. The
protein translated from an overlapping open reading
rame of P protein exists in two respirovirus, SV and
PIV3 (Giorgi et al., 1983; Spriggs and Collins, 1986). In
espirovirus, other than hPIV1 (Matsuoka et al., 1991),
he P mRNA is correct transcript from the vRNA, and the
mRNA is edited mRNA. In rubulavirus including hPIV2,
L cells (B) were infected with rPIV2 (F, ) or rPIV2V(2) (n, l) under
sence (—) of anti-IFN-b antibody. The virus titers were determined at
re expressed as 50% tissue culture infectious dose (TCID50).) and Fowever, the C ORF is missing, the V protein is encoded
y the faithful copy from the vRNA, and the P protein is
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107RECOVERY OF V KNOCKOUT RECOMBINANT HPIV2encoded by the mRNA after pseudotemplated transcrip-
tional addition of nucleotides. Furthermore, the hPIV2 V
protein is a structural protein detected in the virion (Ohgi-
moto et al., 1990), whereas the V and C proteins of SV
ere nonstructural proteins (Lamb and Choppin, 1977).
ato et al. (1997) reported that V(2) SV showed remark-
bly attenuated in vivo replication capacity and pathoge-
icity for mice and proposed that the V protein has a
uxury function required for in vivo replication. In addition,
otoh et al. (1999) have recently reported that the 4C
nockout SV completely loses the ability to suppress the
FN signaling. However, the cells infected with V(2) SV
howed a high resistance to IFN activity (Gotoh et al.,
999). These findings show that the C protein plays an
FIG. 6. Cytopathogenic effect induced by rPIV2 and rPIV2V(2). CV-1
and FL cells were infected with rPIV2V(2) (A) or rPIV2 (B) under
multiple-cycle growth conditions (an m.o.i. of 0.01) in the presence or
absence of anti-IFN-b antibody. After incubation for 24, 48, and 72 h, the
cells were fixed and stained with Giemsa’s solution.mportant role in blocking IFN-mediated cellular re-
ponses.On the contrary, Didcock et al. (1999) have reported
hat expression of the SV5 V protein, a structural protein,
nhibits IFN signaling and induces the degradation of
TAT1 in the absence of other virus proteins. However,
ince the expression of only SV5 P protein sharing the
irst 164 amino acid with V protein did not block the IFN
ignaling (Didcock et al., 1999), we speculated that the
-protein-specific cysteine-rich region participates in
locking the IFN signaling. Therefore, we created
PIV2V(2) devoid of the V-specific cysteine-rich domain
nd analyzed the properties of rPIV2V(2). The rPIV2
ould efficiently replicate in Vero, CV-1, and FL cells,
hile rPIV2V(2) did not multiply in CV-1 and FL cells at
ll. The rPIV2V(2) is able to grow in only Vero cells
nown as IFN nonresponders. In rPIV2V(2)-infected FL
ells, the growth of rPIV2 was clearly recovered, though
f lower yields, by adding anti-IFN-b antibody to the
upernatant of those cells. These findings indicate that
o replication of rPIV2V(2) in CV-1 and FL cells is mainly
ue to interference by the endogenously produced IFN
uring the course of infection, and the resistance against
FN can not be induced by infection with rPIV2V(2). This
hows that the V-specific cysteine-rich C terminus of the
PIV2 V protein, composed of 58 amino acids, pos-
esses the function blocking the antiviral action by IFN.
Kurotani et al. (1998) have reported that the SV C
roteins are categorically nonessential gene products
ut greatly contribute to full replication in tissue culture
ells and pathogenicity for mice. Furthermore, Hasan et
l. (2000) have reported that the accessory and basically
onstructural C proteins are critically required in the SV
ssembly process, being out of all relation to function to
ounteract the antiviral action of interferon-a/b. Since
Vero cells are known as an IFN nonproducer, we inves-
tigated whether relatively low virus yield of rPIV2V(2) in
Vero cells was related to the inefficient assembly of the
rPIV2V(2). Under the multiple-cycle growth conditions,
rPIV2V(2) slowly replicated in Vero cells, and the virus
yield was reduced by ;1 log (48 h p.i.) and 2 logs (72 h
p.i.) lower than those of the rPIV2. On the other hand, the
syntheses of viral mRNAs and proteins were larger in
quantity in rPIV2V(2) infection than that in rPIV2 infection
until 48 p.i., while at 72 h p.i., the situation was reversed.
Furthermore, there were no differences between the
vRNA syntheses of rPIV2V(2) at 24 and at 48 h p.i., while
amounts of other viral components increased together
from 24 to 48 h p.i. These findings indicate that the
infectivity of the progeny virus of rPIV2V(2) decreases
but genomic RNA synthesis ability of rPIV2V(2) is not
impaired. Also, though the infective titer of rPIV2V(2) at
72 h p.i. was almost the same with that of rPIV2 at 48 h
p.i., the synthetic quantities of the viral proteins and
mRNAs of rPIV2V(2) at 72 h p.i. were clearly detected
with much larger than those of rPIV2 at 48 h p.i. These
suggest that the assembly process is impaired in
rPIV2V(2)-infected cells. This speculation was sup-
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108 KAWANO ET AL.ported by observation of viral morphology using an im-
munoelectron microscopy. The rPIV2 and wtPIV2 showed
the typical character of paramyxovirus, possessing a
relatively homogenous population of spherical particles
with a diameter of ;100–200 nm, whereas rPIV2V(2)
isplayed the heterogeneous population, and large
pherical particles (250–500 nm) were frequently found.
hus, it is inferred that the V-specific cysteine-rich do-
ain of C terminus of V protein plays an important role in
he assembly, maturation, and morphogenesis of hPIV2.
As described above, the hPIV2 V protein will be
equired in the assembly and maturation process. In
aramyxoviruses, the M protein has been thought to
lay a critical role in assembly and maturation. The C
rotein of SV responsible for virus assembly colocal-
zed with the M and HN proteins perfectly and pretty
ell, respectively (Hasan et al., 2000). Furthermore,
he internal proteins, the P and L proteins, were found
o distribute diffusely throughout the cytoplasm and
N tended to aggregate on the cell surface in 4C(2)
SV-infected CV-1 cells (Hasan et al., 2000). On the
ontrary, the V protein of hPIV2 was detected domi-
antly in the nucleus (Watanabe et al., 1996) and has
n ability of associating with the internal protein, NP
rotein (Nishio et al., 1996). When Vero cells were
nfected with rPIV2V(2) and stained with anti-NP or
nti-P antibody, both viral proteins were found to dis-
ribute granularly throughout the cytoplasm similar to
hose found in rPIV2 and wtPIV2 (data not shown).
ubsequently, the HN protein was stained on the
PIV2- and rPIV2V(2)-infected cells. The staining pat-
ern of rPIV2V(2) HN protein was different from that of
PIV2 HN protein; that is, the specific fluorescence
as glanular in rPIV2-infected cells, while it showed
iffuse pattern in rPIV2V(2)-infected cells (unpub-
ished data). However, the distribution pattern of the M
rotein could not be identified due to low titer of our
ntibody. It remains to be defined whether the asso-
iation of the V protein with the HN or M protein is
equired for the assembly processes.
Several properties have been ascribed to the V protein
f Paramyxovirus. The V protein of hPIV2 has one binding
omain to the NP protein in the P–V common domain,
hich is located in the N-terminal region, aa1–46 (Nishio
t al., 1996). The V protein in the cells infected with hPIV2
r transfected with the V-specific cDNA clone localized in
he nuclei of the cells (Watanabe et al., 1996; Nishio et al.,
997, 1999). Two noncontiguous regions in the hPIV2 V
rotein, aa1–46 and aa175–196 (cysteine-rich V-specific
omain), are required for nuclear localization and reten-
ion (Watanabe et al., 1996). The V protein of SV5 also
nteracts with both viral NP and cellular proteins (dam-
ge-specific DNA binding protein) (Lin et al., 1998). Re-
cently Lin and Lamb (2000) have reported that slow
progression of the cell cycle is observed in the cells
infected with SV5 or expressing the SV5 V protein. In
f
paddition, the V protein of SV5 has been recently reported
to be responsible for the virus-mediated inhibition of IFN
signaling (Didcock et al., 1999). We clarified in this study
that the V protein of hPIV2 also has an ability of coun-
teracting IFN action. Young et al. (2000) have recently
reported that there is a specific loss of STAT2 in hPIV-2-
infected cells. Furthermore, the V protein of hPIV2 was
found to be related to virus assembly and morphogene-
sis.
In summary, we established the reverse genetic tech-
nique of hPIV2 and isolated infectious recombinant vi-
ruses from the cDNA clones. Furthermore, we isolated
and analyzed the V protein knockout hPIV2. Replication
of rPIV2V(2) was self-limiting in the culture cells. At least
two mechanisms play important roles in self-limiting
growth of rPIV2V(2), namely, (1) the rPIV2V(2) is highly
sensitive to IFN and that no growth of rPIV2V(2) in CV-1
and FL cells is mainly due to its hypersensitivity to
endogenously produced IFN and (2) virus assembly is
impaired in rPIV2V(2)-infected cells.
MATERIALS AND METHODS
Cells and virus preparations
Monolayer cultures of Vero, CV-1, and FL cells and
human parainfluenza type 2 virus (hPIV2), Toshiba strain,
were used in this study. Virus propagation and purifica-
tion were performed as previously reported (Ito et al.,
1987). Chick embryo fibroblasts (CEF) were grown as
described previously (Ito et al., 1974). Modified vaccinia
virus Ankara (MVA) expressing bacteriophage T7 RNA
polymerase, which was kindly provided by Dr. Bernard
Moss (National Institutes of Health, Bethesda, MD) was
grown in CEF cells (Sutter et al., 1995; Wyatt et al., 1995).
Reverse transcriptase–PCR amplification (RT–PCR)
Total RNA was extracted from hPIV2-infected Vero
cells using TRIZOL Reagent (Gibco-BRL), according to
the manufacturer’s protocol. Reverse transcription (RT)
was performed with SuperScriptII (Gibco-BRL). The oli-
gonucleotide primers that annealed to the vRNA(2)
strand were described in Table 1. Before reverse tran-
scription, 5 mg of RNA and 20 pmol of primer were
incubated at 70°C for 5 min and then chilled on ice. RT
reaction mixtures contained this heat-denatured RNA
and 200 U reverse transcriptase in a final volume of 20 ml
ere incubated at 42°C for 45 min. Five to 10 ml of RT
roduct was then amplified in PCR reaction (a total
eaction volume of 50 ml) using appropriate oligonucle-
tide primer pairs (see Table 1 and Fig. 1). Briefly, the RT
roduct and the primers were preheated at 94°C for 1
in and then subjected to 30 cycles, each cycle at 98°Cor 30 s and 68°C for 15 min using Takara LA Taq DNA
olymerase.
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109RECOVERY OF V KNOCKOUT RECOMBINANT HPIV2Construction of a full-length cDNA of the hPIV2
genome
To facilitate the ligation of long RT–PCR products, we
improved the multi-cloning site (MCS) in pUC118 plasmid
vector. Namely, the MCS was replaced with the following
double strand oligonucleotides, 59-GAATTCGATATCGTC-
GACGCATGCGAGCTCAGATCTGCG GCCGCGGTACC-
CTCGAGGGTTACCGGATCCCCCGGGAAGCTTGGG-39,
annealed to its complementary oligonucleotide. The re-
sulting restriction enzyme site order is 59-EcoRI-EcoRV-
SalI-SphI-SacI-BglII-NotI-KpnI-XhoI-BstPI-BamHI-SmaI-
HindIII-39. We named this improved vector pUCRVG. We
synthesized appropriate oligonucleotide primer pairs as
shown in Table 1 and performed the RT–PCR using vRNA
as a template. As shown in Fig. 1, cDNA fragment 1 of
five RT–PCR products overlapping at the restriction en-
zyme site was amplified by PCR using the primer 1
(positive sense), which included 59-SalI site-T7 promoter
(17nt)-3G-hPIV2 leader sequence (21nt), while the primer
2 (negative sense) contained 59-NotI site (extra nucleo-
tides for genetic tag)-AGAT (extra nucleotides for rule of
six)-complementary to hPIV2 nt 102–125. Likewise, frag-
ment 2 was amplified using the primer 3 including 59-
NotI-hPIV2 nt 126–151 (on NP gene) and the primer 4
including complementary to hPIV2 nt 2659–2691 (con-
taining SacI on V/P gene). Fragments 3 and 4 were
amplified using the primer pairs 5 (nt 2659–2691) and 6
(complementary to nt 8122–8154) and 7 (nt 8122–8154)
and 8 (complementary to nt 10,012–10,045) containing
the restriction enzyme sites described above, SacI, KpnI,
pnI and BstPI, respectively. Fragment 5 was amplified
sing the primer pairs 9 (nt 10,012–10,045) and 10, which
ncluded the sequence complementary to 59-SmaI site-
epatitis delta virus ribozyme (84 nt)-hPIV2 trailer (27 nt).
hese RT–PCR fragments were digested with restriction
nzymes in both termini and subcloned into pUC118RVG
lasmid vector. Then the plasmid including the full-length
PIV2 cDNA genome (pPIV2) was constructed by step-
ise assembly from these subcloned plasmid DNAs
sing standard molecular biology techniques.
onstruction of hPIV2 genome cDNA devoid of V
ene
To generate a stop codon in 8 nt downstream of the
NA-editing site of the V gene, one nucleotide change
AGA to TGA) was introduced into the plasmid pPIV2
ontaining the cDNA copy of the full-length hPIV2 anti-
enome. Consequently, the following primers, a pair of
omplementary oligonucleotide primers, (59-GG-
AGCTAATtG AGAAAGAGCAAG-39 and 59-CTTGCTCTT-
CTCaATTAGCTCCC-39), which contained a mutation
shown by lower-case letters) and outer primers, 59-
CTGTTCTAACTAGTGCAG CGGAT-39 (including SpeIite) and 59-CAAGTCCCTTTAAGAGCTCAATGATCTC-
TTC A-39 (including SacI site) were used for generation
Hf the mutated DNA fragment by two-step PCR-based
verlap primer extension (Steffan et al., 1989). PCR was
erformed with the template, pPIV2, for 25 cycles of
4°C, 1 min, 60°C, 1 min, and 72°C, 1 min. The amplified
ragments were digested with SpeI and SacI and in-
erted into similarly digested plasmid including the RT–
CR fragment 2 described above (Fig. 1) and then simi-
arly inserted into pPIV2 digested with NotI and SacI.
his plasmid was designated pPIV2V(2).
ransfection and recovery of viruses from cDNAs
Vero cells at 90–95% confluence in a six-wells plate
ere infected with MVA at an m.o.i. of 1, and after 2 h, the
lasmid pPIV2 and the plasmids encoding NP, P, and L,
hich were under control of T7 promoters in bluescriptII
ector (p2NP, p2P, and p2L, respectively) were trans-
ected into cells with LIPOFECTAMINE 2000 Reagent
Gibco–BRL). The amounts of plasmids were as follows:
mg pPIV2, 2 mg p2NP, 0.25 mg p2P, and 2 mg p2L per
well. After incubation for 6 h, the transfection media were
changed to MEM containing 5% fetal calf serum. After
incubation for 40 h at 37°C, the cells were detached and
harvested by a cell scraper and then were cocultured
with fresh Vero cells. After 2 days of incubation, the
media were harvested and then further inoculated into
Vero cells, and the supernatant was filtered through 0.22
mM filter to remove MVA. High-titer virus was generated
by infecting Vero cells or CV-1 cells, which was used as
the stock virus for all the experiments. The hPIV2 recov-
ered from pPIV2 cDNA was designated rPIV2. Also, the
hPIV2 recovered from pPIV2V(2) cDNA by using the
same manipulation was designated rPIV2V(2).
RT–PCR/Southern blot analysis
Total RNA was extracted with Trisol reagent (Gibco–
BRL). RNA yields were determined spectrophotometri-
cally. The RNA from rPIV2- or rPIV2V(2)-infected cells
was examined using RT–PCR followed by Southern blot-
ting with an hPIV2-specific radioactive probe. Five-micro-
gram aliquots of each RNA preparation were reverse
transcribed by the SuperscriptII reverse transcriptase
(Gibco–BRL) and oligo dT- or primer 1 (Table 1) in a
reaction volume of 20 ml. Five microliters of RT products
were used as PCR templates. The rPIV2 or rPIV2V(2)-
specific fragment was amplified with the appropriate
primer. Thermal cycling conditions were as follows: the
reaction mixture was incubated at 94°C for 1 min fol-
lowed by 15 cycles of 94°C for 1min, 60°C 1 min, and
72°C for 1.5 min using Takara EX Taq DNA polymerase in
a reaction volume of 100 ml.
After PCR amplification, 10 ml of the total reaction were
ractionated on a 1% agarose gel and transferred onto a
1ybond N membrane (Amersham) under alkaline con-
ditions. The RT–PCR products were visualized by South-
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110 KAWANO ET AL.ern hybridization with the hPIV2- and actin-specific
probes.
Western blot assays and antibodies
The virus-infected cells were washed twice with PBS,
dissolved with 100 ml of sample buffer [100 mM Tris–HCl
(pH 6.8), 4% SDS, 20% glycerol, 0.1% bromphenol blue,
10% 2-mercaptoethanol] per well in 12-well plate and
sonicated. Twenty-five microliters of the 100 ml cell ly-
sates were analyzed by SDS–PAGE and electroblotted
onto nitrocellulose membranes. The membranes were
blocked with 5% skim milk in PBS, treated with each
monoclonal antibody (MAb) at room temperature for 1 h,
washed three times with 0.05% Tween 20 in PBS (PBS/T),
and treated with biotinylated secondary antibody for 30
min. After washing with PBS/T, the membranes were
treated with avidin-biotin-peroxidase complex (Vector
Laboratories) at room temperature for 30 min. After
washing with PBS, the membranes were immersed in
PBS containing 0.3% 4-chloro-1-naphthol and 0.009% hy-
drogen peroxide. For Western blot assays, MAbs against
hPIV2-NP (64-1A) and -P/V (315-1) (Tsurudome et al.,
989) were used.
irus purification
When the virus-infected Vero cells showed extensive
PE, a large amount of culture supernatant (500 ml) of
he cells was collected and then was centrifuged at 1500
for 5 min at 4°C. The surpernatant was centrifuged
gain at 10,000 g for 12 h at 4°C. The virus pellet resus-
pended in TNE buffer [50 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 1 mM EDTA] was layered on a 50%/20% (w/w)
discontinuous sucrose density gradient in TNE buffer
and centrifuged at 100,000 g for 12 h at 4°C. Sucrose
fraction (1 ml) was collected from the interface between
50 and 20% sucrose. The sucrose fraction was diluted in
12 ml of PBS (pH 7.4), and spun down at 100,000 g for 2 h
at 4°C. The pellet was suspended in 100 ml of PBS.
lectron microscopy (EM) and immune electron
icroscopy (IEM)
For conventional EM, 3 ml of each virus sample was
pplied to Formvar-coated and carbon-vaporized grids
nd then negatively stained with 2% phosphotungstic
cid (pH 6.5). The grid was assessed using a Hitachi
-800 electron microscope. IEM was performed using
ouse anti-hPIV2 HN monoclonal antibody as a primary
ntibody, and goat anti-mouse IgG colloidal gold parti-
les (5-nm diameter; BioCell Research Laboratories,
ardiff, UK) as a secondary antibody. Briefly, 3 ml of each
irus sample was adsorbed on the grid and then the
emidried grid was floated for 5 min on a drop of TBS–
SA [100 mM Tris–HCl (pH 7.6), 150 mM NaCl, and 2%
ovine serum albumin] placed on a parafilm in a moist
hamber. The grid was then floated for 30 min on a drop
Gf TBS containing 3% gelatin and then the excess of
elatin was washed away from the drop of TBS–BSA.
he grid was incubated for 60 min on a drop of primary
ntibody solution (diluted 1:100 in TBS–BSA) at room
emperature and then washed three times with TBS–
SA. After incubating the grid for 60 min in a drop of
econdary antibody solution (diluted 1:20 in TBS–BSA),
he grid was washed three times with TBS–BSA and
nce with TBS. The grid was negatively stained with 2%
hosphotungstic acid for observation by an electron mi-
roscope.
iral replication in the presence of anti-IFN-b
antibody
FL and CV-1 cells grown in 12-well plated were in-
fected with rPIV2 or rPIV2V(2) at an m.o.i. of 0.01. After
2 h of incubation, the inoculum was removed, and the
cells were further cultured with MEM (supplemented
with 1% FCS) containing antibody against human IFN-b
(800 U/ml) or no antibody. At 24, 48, and 72 h p.i., the
titers of the virus were determined by CPE method using
Vero cells, and virus titers were expressed as 50% tissue
culture infectious dose (TCID50).
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